Byetta, Januvia Lawyers Meet with MDL Judge
A conference today regarding pancreatic cancer lawsuits involving Byetta, Januvia and similar diabetes drugs will tackle key issues regarding the litigation.…
«
»
A conference today regarding pancreatic cancer lawsuits involving Byetta, Januvia and similar diabetes drugs will tackle key issues regarding the litigation.…
A medical journal finds that collected data indicates that metformin cannot be used to decrease heart risk in people without diabetes.…
The diabetes drug Metformin appears to affect men and women’s hearts differently, according to a new study that raises questions about gender differences in a number of diabetes drugs.…
A Master complant and short complaint approved for the filing of pancreatic cancer lawsuits against makers of Byetta, Januvia and Victoza.…
The science behind diabetes, the drugs that treat it, and pancreatic cancer will be the subject of an upcoming science day involving litigation over Byetta and Januvia.…
A new study provides further evidence of the link between a risk of pancreatic damage and use of increatin mimetic diabetes drugs.…
In the federal MDL, plaintiffs facing end of life from pancreatic cancer may preserve testimony for trial by noticing an In Extremis deposition.…
Attorneys have been appointed to leadership roles as incretin mimetic pancreatic cancer lawsuits move forward.…
A new study shows that Byetta could reduce the risk of Avandia heart attacks and also shows how the FDA’s adverse event reporting system could identify helpful drug combinations.…
Attorneys seek leadership roles in MDL established for Byetta, Victoza, Janumet and Januvia lawsuits.…